K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation
Conditions: Non-small Cell Lung Cancer Metastatic Interventions: Radiation: Stereotactic body radiation therapy (SBRT); Drug: Temporary Stopping Sponsors: Karolinska University Hospital; Sahlgrenska University Hospital, Sweden; Amgen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hospitals | Lung Cancer | Non-Small Cell Lung Cancer | Radiation Therapy | Research | Sweden Health